ARTIRIA Medical is pioneering advancements in neurovascular treatment with its innovative deflectable guidewire technology, designed to enhance the minimally invasive treatment of strokes. This guidewire features a real-time deflectable tip that can be actively controlled via a unique handle, allowing for precise navigation through complex vascular anatomies. The design addresses significant challenges faced by neurointerventional surgeons, such as tortuosity and the need for tip reshaping, thereby facilitating quicker access to neurovascular targets. The guidewire's advanced coating further improves trackability and navigation through the intricate network of brain arteries, which is crucial in emergency situations where time is of the essence.

The company is committed to revolutionizing neurointerventional procedures, having already achieved FDA clearance for its guidewire and initiated first-in-human clinical studies. ARTIRIA Medical's focus on addressing the pressing medical need for effective stroke treatment is underscored by its successful funding rounds and collaborations with key opinion leaders in the field. By leveraging cutting-edge technology, ARTIRIA aims to set a new standard of care for stroke patients, ultimately improving outcomes and saving lives in a landscape where approximately 12 million strokes occur annually worldwide.

Switzerland

Artiria Medical is a Swiss neurovascular company that empowers catheters and guidewires, developing cutting-edge technologies to revolutionize the limits of neurointerventional procedures. Their medical device offers navigation in brain arteries and stroke treatment, allowing for the treatment of vascular diseases. The company has secured FDA clearance for their real-time, deflectable guidewire and has received funding to advance stroke treatment technology in Europe and the US.

ARTIRIA Medical

Company Details